Exploring Bioactive Compounds of Rauvolfia tetraphylla L. (RT) for 3CLprotease of SARS-CoV2: GC-MS Analysis and In-Silico Studies-Reference-Cited by-同舟云学术

Exploring Bioactive Compounds of Rauvolfia tetraphylla L. (RT) for 3CLprotease of SARS-CoV2: GC-MS Analysis and In-Silico Studies

Published:2024-07-20 Issue: Volume: Page:
ISSN:1085-9195
Container-title:Cell Biochemistry and Biophysics
language:en
Short-container-title:Cell Biochem Biophys

Author:

Ramakrishnan Gnanasekaran,Gujjula Koteswara Reddy,Mekala Janaki Ramaiah,Sai Sree Thanay A.,Praveen T.,Priyanka H.,Govind Geya,Sesha Bhavana J.,Shaik Baji,Varakala Nikhil Reddy

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12013-024-01421-7.pdf

Reference33 articles.

1. Lin, E. C., Chiang, Y. C., Lin, H. Y., Tseng, S. Y., Hsieh, Y. T., Shieh, J. A., & Lee, I. T. (2023). Unraveling the link between periodontitis and coronavirus disease 2019: exploring pathogenic pathways and clinical implications. Biomedicines, 11(10), 2789.

2. Gavilán, E., Medina-Guzman, R., Bahatyrevich-Kharitonik, B., & Ruano, D. (2024). Protein Quality Control Systems and ER Stress as Key Players in SARS-CoV-2-Induced Neurodegeneration. Cells, 13(2), 123.

3. Haghir Ebrahim Abadi, M. H., Ghasemlou, A., Bayani, F., Sefidbakht, Y., Vosough, M., Mozaffari-Jovin, S., & Uversky, V. N. (2024). AI-driven covalent drug design strategies targeting main protease (mpro) against SARS-CoV-2: structural insights and molecular mechanisms. Journal of Biomolecular Structure and Dynamics, 1–29.

4. Naqvi, A. A. T., Fatima, K., Mohammad, T., Fatima, U., Singh, I. K., Singh, A., & Hassan, M. I. (2020). Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1866(10), 165878.

5. Mohanty, S., Paul, S., & Ahmad, Y. (2021). Understanding the SARS-CoV-2 virus to mitigate current and future pandemic (s). Virus Disease, 32(3), 390–399.